Skip to content
Screener

Arcutis Biotherapeutics, Inc. ARQT Prepaid & Other Current

Prepaid & Other Current at other companies

Amgen logo
AmgenAMGN
$4.53B+32.2%
Incyte logo
IncyteINCY
$253.09M-14.4%
PVL
Palvella TherapeuticsPVLA
$1.38M-24.9%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$7.11M-60.4%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$26.28M+14.9%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
$4.79M+10.2%

Other financials

Income statement

See full
Revenue$129.9M+59.3%
Gross profit$118.9M+60.7%
Operating income$16.4M+212%
Net income$15.0M+194%
EPS (diluted)$0.11+185%

Balance sheet

See full
Cash & equivalents$34.4M-52.9%
Total debt$114.1M+3.6%
Total equity$220.6M+58.7%
Total assets$488.5M+38.6%

Cash flow

See full
Operating cash flow$12.6M
CapEx$158.0K+103%
Free cash flow$12.5M

Valuation

See full
Market cap$3.18B+86.8%
Enterprise value$3.26B+87.4%
P/S6.9×+0.4×

Profitability

See full
Gross margin91.1%+2.0pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.5×-0.3×
Current ratio2.9×-0.3×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →

Filed
Aug 5, 2026, 4:21 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001787306-26-000051

FAQ

What is Arcutis Biotherapeutics, Inc.'s prepaid & other current?
Arcutis Biotherapeutics, Inc. (ARQT) reported prepaid & other current of $34.77M in Q2 2026.
How has Arcutis Biotherapeutics, Inc.'s prepaid & other current changed year-over-year?
Arcutis Biotherapeutics, Inc.'s prepaid & other current increased by 86.6% year-over-year, from $18.64M to $34.77M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s prepaid & other current?
Over 4 years (2021 to 2025), Arcutis Biotherapeutics, Inc.'s prepaid & other current has grown at a 7.0% compound annual growth rate (CAGR), from $63.28M to $82.96M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.

Ask your AI about Arcutis Biotherapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude